Pacira Launches State-of-the-Art Training Center Dedicated to Advancing Best Practice Regional Approaches to Manage Acute Pain
The PITT is a fully adaptable environment constructed with guidance and input from leaders in the field of regional anesthesia, and is equipped with state-of-the-art technology and audio/visual capabilities to support a full range of educational events from didactic presentations to hands-on workshops.
“The rapid advancement of ultrasound-guided regional anesthesia techniques, coupled with longer-acting local anesthetics, have made it possible for clinicians to provide precise, prolonged non-opioid pain management for surgical procedures ranging from the chest wall and abdomen to the spine and major joints,” said
The PITT features several distinct training spaces including a simulation lab equipped with seven ultrasound scanning stations; a lecture hall featuring a 4.5-foot-tall by 24-foot-wide LCD video wall to support live, virtual and even global presentations; and a green-screen broadcast studio designed to livestream content with single or multiple hosts.
“The ability to share innovative best practice techniques and insights not only in a live format but also simultaneously with peers across the country and beyond is essential to advancing our understanding of the evolving discipline of regional and field blocks to manage acute pain,” said
Among other programs, Pacira will host ongoing workshops to train new users on best practice techniques for iovera° administration at the PITT. Led by healthcare professionals, these labs will include didactic lectures and hands-on trainings including live model nerve scanning and identification using ultrasound and peripheral nerve stimulation. The PITT will also serve as a venue for national anesthesia provider organizations to host their own workshops and training sessions.
“Non-opioid pain management provides the catalyst for the increasing shift of inpatient procedures to the 23-hour stay environment, which directly correlates with patient outcomes and satisfaction rates,” said
About Pacira BioSciences
The ioverao system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. In one study, the majority of the patients suffering from osteoarthritis of the knee experienced pain and system relief beyond 150 days.1 The ioverao system’s “1×90” Smart Tip configuration (indicating one needle which is 90 mm long) can also facilitate target nerve location by conducting electrical nerve stimulation from a separate nerve stimulator. The ioverao system is not indicated for treatment of central nervous system tissue.
Important Safety Information
The ioverao system is contraindicated for use in patients with the following: Cryoglobulinemia; Paroxysmal cold hemoglobinuria; cold urticaria; Raynaud’s disease; open and/or infected wounds at or near the treatment line. Potential complications: As with any surgical treatment that uses needle-based therapy, there is potential for temporary site-specific reactions, including but not limited to: bruising (ecchymosis); swelling (edema); inflammation and/or redness (erythema); pain and/or tenderness; altered sensation (localized dysesthesia). Typically, these reactions resolve with no physician intervention. Patients may help the healing process by applying ice packs to the affected sites, and by taking over-the counter analgesics.
Source: Pacira BioSciences